Multiplicity and replicability: two sides of the same coin

被引：9

作者：

Bretz, Frank ^{[1
]}

Westfall, Peter H. ^{[2
]}

机构：

[1] Novartis Pharma AG, Basel, Switzerland

[2] Texas Tech Univ, Lubbock, TX 79409 USA

来源：

PHARMACEUTICAL STATISTICS | 2014年 / 13卷 / 06期

关键词：

reproducibility; selective inference; subgroup analysis; PHASE-II;

D O I：

10.1002/pst.1648

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：343 / 344

页数：2

共 17 条

[1]

Phase II failures: 2008-2010 [J].

Arrowsmith, John .

NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) :1-1

[2]

Selection and bias-Two hostile brothers [J].

Bauer, Peter ;

Koenig, Franz ;

Brannath, Werner ;

Posch, Martin .

STATISTICS IN MEDICINE, 2010, 29 (01) :1-13

[3]

Bergers J., 2012, REPROD SCI P VALUES

[4]

Bretzs F, 2010, MULTIPLE COMP USING

[5]

Replicating genotype-phenotype associations [J].

Chanock, Stephen J. ;

Manolio, Teri ;

Boehnke, Michael ;

Boerwinkle, Eric ;

Hunter, David J. ;

Thomas, Gilles ;

Hirschhorn, Joel N. ;

Abecasis, Goncalo ;

Altshuler, David ;

Bailey-Wilson, Joan E. ;

Brooks, Lisa D. ;

Cardon, Lon R. ;

Daly, Mark ;

Donnelly, Peter ;

Fraumeni, Joseph F., Jr. ;

Freimer, Nelson B. ;

Gerhard, Daniela S. ;

Gunter, Chris ;

Guttmacher, Alan E. ;

Guyer, Mark S. ;

Harris, Emily L. ;

Hoh, Josephine ;

Hoover, Robert ;

Kong, C. Augustine ;

Merikangas, Kathleen R. ;

Morton, Cynthia C. ;

Palmer, Lyle J. ;

Phimister, Elizabeth G. ;

Rice, John P. ;

Roberts, Jerry ;

Rotimi, Charles ;

Tucker, Margaret A. ;

Vogan, Kyle J. ;

Wacholder, Sholom ;

Wijsman, Ellen M. ;

Winn, Deborah M. ;

Collins, Francis S. .

NATURE, 2007, 447 (7145) :655-660

[6]

CPMP, 2002, Points to consider on multiplicity issues in clinical trials

[7]

Dmitrienkos A, 2009, MULTIPLE TESTING PRO

[8]

Estimation and Accuracy After Model Selection [J].

Efron, Bradley .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2014, 109 (507) :991-1007

[9]

Food and Drug Administration. Center for Drugs Evaluation Research, 2014, DRAFT GUID IN PRESS

[10]

Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer [J].

Gan, Hui K. ;

You, Benoit ;

Pond, Gregory R. ;

Chen, Eric X. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (08) :590-598

← 1 2 →